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The Stingray LP balloon (Boston Scientific, Marlborough, MA) is fre-
quently used to facilitate distal true lumen re-entry in case of subintimal
guidewire entry during chronic total occlusion (CTO) percutaneous cor-
onary intervention (PCI) [1,2]. There is limited data on the failuremodes
of the Stingray LP balloon.
We investigated the Manufacturer and User Facility Device Experi-
ence (MAUDE) database for reports on Stingray LP failure from January
2016 to December 2020 (the device was approved in December 2015).
The database was last accessed on January 3rd, 2021, by two indepen-
dent reviewers (RM and MM). The MAUDE database is publicly avail-
able and de-identified and no institutional review board approval was
required. The outcomes this study was the modes of failure and their
clinical consequences. The percentages reported in the study represent
only the events reported to the MAUDE registry and doesn't represent
the overall complications of the Stingray LP balloon as the denominator
is unknown.
A total of 95 reports were found during the study period. After ex-
cluding duplicates and irrelevant reports (n = 23), reports on the
initial Stingray balloon (n = 16), and Stingray wire reports (n =
5), our final cohort included 51 reports. The most common mode of
failure was balloon rupture after delivery (45%), followed by failure
of the wire to pass through the catheter (15.7%), and shaft fracture
(15.7%) (Table 1). Serious clinical consequences were rare with no
injury to the patient in 96% of the reports and completed procedure
in 87%. Coronary perforation and tamponade occurred in 1 report,
emergency cardiac surgery was required in 1 report and no patients
died.
Our study is the first to describe the modes of failure of Stingray LP
balloon since its approval in 2015. We found that reports on Stingray
LP failure were rare (51 over 5 years) with no significant clinical conse-
quences in most cases. The most common Stingray LP balloon malfunc-
tion was rupture after delivery. This could be due to balloon
deformation during aggressive advancement attemtps, for example
through heavily calcified and tortuous coronary segments. Another po-
tential cause of rupture is inflation of the Stingray LP balloon at higher
than recommended (3–4 atm is recommended in the instructions for
use) pressure.
Preparing the subintimal track can facilitate delivery of the Stingray
LP balloon, but also carries a risk of creating a subintimal hematoma that
could hinder subsequent reentry attempts. Microcatheter advancement
to the reentry zone usually suffices, although in some cases inflation
with a small (1.0–1.5 mm) balloon may be required. Aggressive ad-
vancement attempts should be avoided as they can compromise the
structural integrity of the Stingray LP balloon, that may lead to kinking
of the balloon shaft that may not allow subsequent guidewire insertion
(15.7% of the reports) and could even lead to balloon shaft fracture
(15.7% of the reports).
Inability to visualize the balloon was the mode of failure in 11.8% of
the reports. This is likely related to suboptimal balloon preparation,
which is laborious requiring aspiration with a 20 cm3 dry syringe X 3,
followed by connection with a 3 cm3 syringe that contains 100% con-
trast. Multiple views and use of higher magnification can help better vi-
sualize the Stingray LP balloon and its relation with the distal true
lumen. Alternatively, the “double blind stick and swap technique” can
be used for reentry [3], during which a stiff guidewire is advanced
through both exit ports of the Stingray balloon, followed by exchange
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for a polymer jacketed guidewire that is also advanced through both
exit ports until reentry is achieved.
Failure to cross the lesion was the mode of failure in 5.7% of the re-
ports, although this does not represent an inherent device failure. Fail-
ure to cross may be due to subintimal hematoma formation that could
be reduced by aspiration, either though the Stingray balloon itself or
through an over the wire balloon or a microcatheter [4,5]. Alternatively
the reentry zone may be moved more distally (“bobsled” technique).
Reentry failuremay also bedue to heavy calcification that could be over-
come by using stiff tip guidewires.
Our study is limited by the selection bias resulting from the retro-
spective analysis from the MAUDE and selective optional reporting by
healthcare professionals. Moreover, the incidence of each mode of fail-
ure cannot be accurately determined as the study lacks a denominator.
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Table 1
Complications and failuremodes of Stingray LP balloon as reported to theMAUDE registry.
N = 51
Target vessel, n (%)
Left anterior descending artery 10 (19.6%)
Left circumflex 2 (3.9%)
Right coronary artery 22 (43.1%)
Not mentioned 17 (33.3%)
Failure mode, n (%)
Balloon rupture after delivery 23 (45.1%)
Failure of guidewire to pass through Stingray catheter (stuck wire) 8 (15.7%)
Shaft fracture 8 (15.7%)
Failure to visualize the balloon markers under fluoroscopy 6 (11.8%)
Balloon fracture before delivery 4 (7.8%)
Failure to cross the lesion 3 (5.9%)
Failure of balloon inflation 1 (2%)
Failure of balloon deflation 1 (2%)
Clinical consequences, n (%)
No injury to the patient 49 (96.1%)
Completed percutaneous coronary intervention 43 (87.3%)
Aborted procedure 5 (9.8%)
Coronary perforation leading to tamponade 1 (2%)
Surgery 1 (2%)
Death 0 (0%)
The percentages reported in the study represent only the events reported to the MAUDE
registry and doesn't represent the overall complications of the Stingray LP balloon as the
denominator is unknown.
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